Literature DB >> 20212082

Zebrafish as a model for studying genetic aspects of epilepsy.

Gabriela A Hortopan1, Matthew T Dinday, Scott C Baraban.   

Abstract

Despite a long tradition of using rats and mice to model epilepsy, several aspects of rodent biology limit their use in large-scale genetic and therapeutic drug screening programs. Neuroscientists interested in vertebrate development and diseases have recently turned to zebrafish (Danio rerio) to overcome these limitations. Zebrafish can be studied at all stages of development and several methods are available for the manipulation of genes in zebrafish. In addition, developing zebrafish larvae can efficiently equilibrate drugs placed in the bathing medium. Taking advantage of these features and adapting electrophysiological recording methods to an agar-immobilized zebrafish preparation, we describe here our efforts to model seizure disorders in zebrafish. We also describe the initial results of a large-scale mutagenesis screen to identify gene mutation(s) that confer seizure resistance. Although the adaptation of zebrafish to epilepsy research is in its early stages, these studies highlight the rapid progress that can be made using this simple vertebrate species.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20212082     DOI: 10.1242/dmm.002139

Source DB:  PubMed          Journal:  Dis Model Mech        ISSN: 1754-8403            Impact factor:   5.758


  46 in total

Review 1.  Genetic Discoveries Drive Molecular Analyses and Targeted Therapeutic Options in the Epilepsies.

Authors:  Ryan S Dhindsa; David B Goldstein
Journal:  Curr Neurol Neurosci Rep       Date:  2015-10       Impact factor: 5.081

2.  Issues in Clinical Epileptology: A View from the Bench. A Festschrift in Honor of Philip A. Schwartzkroin, PhD.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2013-11       Impact factor: 7.500

3.  A zebrafish model of hyperammonemia.

Authors:  B Feldman; M Tuchman; L Caldovic
Journal:  Mol Genet Metab       Date:  2014-07-10       Impact factor: 4.797

Review 4.  The genetics of the epilepsies.

Authors:  Christelle M El Achkar; Heather E Olson; Annapurna Poduri; Phillip L Pearl
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

5.  Recording the adult zebrafish cerebral field potential during pentylenetetrazole seizures.

Authors:  Ricardo Pineda; Christine E Beattie; Charles W Hall
Journal:  J Neurosci Methods       Date:  2011-06-12       Impact factor: 2.390

6.  Untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy.

Authors:  Udo Fh Engelke; Rianne E van Outersterp; Jona Merx; Fred Amg van Geenen; Arno van Rooij; Giel Berden; Marleen Cdg Huigen; Leo Aj Kluijtmans; Tessa Ma Peters; Hilal H Al-Shekaili; Blair R Leavitt; Erik de Vrieze; Sanne Broekman; Erwin van Wijk; Laura A Tseng; Purva Kulkarni; Floris Pjt Rutjes; Jasmin Mecinović; Eduard A Struys; Laura A Jansen; Sidney M Gospe; Saadet Mercimek-Andrews; Keith Hyland; Michèl Aap Willemsen; Levinus A Bok; Clara Dm van Karnebeek; Ron A Wevers; Thomas J Boltje; Jos Oomens; Jonathan Martens; Karlien Lm Coene
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 14.808

7.  Novel Vitamin K analogs suppress seizures in zebrafish and mouse models of epilepsy.

Authors:  J J Rahn; J E Bestman; B J Josey; E S Inks; K D Stackley; C E Rogers; C J Chou; S S L Chan
Journal:  Neuroscience       Date:  2013-12-01       Impact factor: 3.590

Review 8.  WONOEP appraisal: new genetic approaches to study epilepsy.

Authors:  Elsa Rossignol; Katja Kobow; Michele Simonato; Jeffrey A Loeb; Thierry Grisar; Krista L Gilby; Jonathan Vinet; Shilpa D Kadam; Albert J Becker
Journal:  Epilepsia       Date:  2014-06-25       Impact factor: 5.864

Review 9.  A roadmap for precision medicine in the epilepsies.

Authors: 
Journal:  Lancet Neurol       Date:  2015-09-20       Impact factor: 44.182

Review 10.  Role of Sodium Channels in Epilepsy.

Authors:  David I Kaplan; Lori L Isom; Steven Petrou
Journal:  Cold Spring Harb Perspect Med       Date:  2016-06-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.